TIME TO TALK ABOUT WOMEN’S HEARTS
Did you know that an estimated 1.2 million Australians are living with some form of cardiac, stroke or vascular disease. And that tragically, one woman loses their life every hour to heart disease – a disease which is 80 per cent preventable? Ischaemic Heart Disease (IHD) represented the second leading cause of death in Australian…
TIME TO SLIP, SLOP, SLAP, SEEK & SLIDE
On Saturday, December 9, 2023, Sydney sweltered through a heatwave that saw our airport reach 43.5 degrees Celsius – a December record. Sydney was not alone, with other NSW locations climbing beyond 40C that day. These high temperatures are set to continue, with experts calling for all Aussies to brace themselves for scorching temperatures up…
Aussies need a nationally consistent vaccination approach
Following a decline in vaccination rates following the peak of the COVID-19 pandemic, a new report is calling for a united, consistent, national approach to vaccinate Australians following a decline in vaccination rates after the peak of the COVID-19 pandemic. The Grattan Institute’s ‘A fair shot: How to close the vaccination gap’ report suggests taking…
New treatment now PBS listed for Australians living with chronic plaque psoriasis
The October 1, 2023 Pharmaceutical Benefits Scheme (PBS) listing of a new, once-daily, oral treatment for severe chronic plaque psoriasis represents good news for the estimated 19,000 Australian adults living with the common inflammatory skin disease. At VIVA! Communications, we are proud to be supporting the communication of this PBS listing announcement, working in partnership…
New Colombian comms partner strengthening our Global Health Marketing & Communications capabilities
To further strengthen our global network’s health communications expertise, Global Health Marketing & Communications (GHMC) today announced the addition of its newest member, Monodual Libera Ideas, a Colombian-based strategic communications, and consulting firm. GHMC is the world’s largest and most robust network of independent healthcare agencies, for which we – VIVA! Communications – have represented…
Tick of approval needed for Alzheimer’s disease medication in AUS
There are calls for the Therapeutic Goods Administration (TGA) to greenlight a breakthrough medication with the potential to slow the progression of Alzheimer’s disease. The Federal Drug Administration (FDA) recently approved humanised monoclonal antibody Lecanemab for use in patients with the neurodegenerative disease, in the wake of promising clinical trial outcomes. The medication, marketed as…
VIVA! Communications clinches gold & two silvers at Public Relations Institute of Australia Golden Target Awards
Team VIVA! was dressed to impress at the annual PRIA Golden Target Awards (GTAs) held at the Sofitel Darling Harbour, Sydney, last night (Thursday, December 1, 2022). A show-stopping 146 finalists representing 35 categories assembled for Australia’s longest-running, and most prestigious public relations and communications awards that both celebrate, and recognise, individuals, agencies and campaigns demonstrating strategic…
VIVA! Communications clinches Best PR Campaign – Awareness and Advocacy with Edwards Lifesciences at the 2022 PRIME Awards
VIVA! Communications marked the 18th annual PRIME Awards in style last night (Thursday, November 10, 2022) together with our much-valued clientele, Edwards Lifesciences and Dr Falk Pharma, and Australian representatives from the pharmaceutical industry, at the Sofitel Wentworth Sydney Hotel. Hosted by comedian, musician and former member of ABC TV’s satirical program, The Chaser,…